Monday, April 24, 2017

FICPA Holds Health Care Industry Conference in Orlando

Health care is a profession under constant change, especially under a new administration. New rules and regulations are introduced with regularity. What can you do to keep pace with this ever-evolving industry? Attendees of the 2017 FICPA Health Care Industry Conference addressed these issues and more. The event was held at the Caribe Royale in Orlando April 20 and 21.

The program featured a morning Keynote Address entitled Information Security: Threats, Attack Vectors and Solutions, led by Robert E. Anderson Jr., Managing Director of Navigant Consulting, Inc. Breakout topics included Physician Independence in an Environment of Growing Complexity, New Revenue Opportunities, Learning From the Past: Regulatory and Transactional Lessons Learned in Healthcare Deals and Building a Personal Brand in Health Care. There was also a Luncheon Presentation focused on the Post Election World for the Health Care Industry, an afternoon Keynote Address called Value as a Driver of Provider Payment and an Expert Panel discussing The Impact of the Presidential Election on Strategy and Alternative Payment Systems.

Sponsors included:
  • South Florida Hospital News & Healthcare Report
  • RSM US LLP
  • American Express
  • Carr, Riggs & Ingram, LLC
  • PNC Health Care
  • FHIcommunications
  • Gregory, Sharer & Stuart, CPAs
  • J.P. Morgan
  • Ernst and Young, LLP
  • Fifth Third Bank
  • Healthcare Financial Management Association - Florida Chapter
  • Memorial Healthcare System
  • KPMG, LLP
  • Moore Stephens Lovelace CPAs & Advisors
  • Navigant Consulting, Inc.
  • Pinnacle Healthcare Consulting
  • Vaco
  • Winthrop Resources
The FICPA has unique conference sponsorship opportunities available that can help increase visibility and exposure of services and products. Conference sponsorship options include table-top exhibits and exclusive sponsorship of lunch, breakfast and/or breaks.

For more information on how to become a sponsor for a future conference, please contact the FICPA at (800) 342-3197, (850) 224-2727 or millerd@ficpa.org.

Monday, April 10, 2017

23andMe Receives FDA Nod

According to an FDA.gov news release dated 4.6.17:

The U.S. Food and Drug Administration (FDA) today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA that provide information on an individual's genetic predisposition to certain medical diseases or conditions, which may help to make decisions about lifestyle choices or to inform discussions with a health care professional.                                 

Read more in the current issue of Week in Review>> http://conta.cc/2nVaaSF